Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

Algazi et al.

  • Clinical Cancer Research
  • June 2020

Immunotherapy of CT26 Murine Tumors Is Characterized by an Oligoclonal Response of Tissue-Resident Memory T Cells Against the AH1 Rejection Antigen

Stringhini et al.

  • European Journal of Immunology
  • May 2020

Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient

Franco-Luzon et al.

  • Cancers
  • April 2020

Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma

Mitra et al.

  • Nature Communications
  • April 2020

Neutrophil Expansion Defines an Immunoinhibitory Peripheral and Intratumoral Inflammatory Milieu in Resected Non-Small Cell Lung Cancer: A Descriptive Analysis of a Prospectively Immunoprofiled Cohort

Mitchell et al.

  • Journal for ImmunoTherapy of Cancer
  • April 2020

Neoadjuvant Immunotherapy Leads to Pathological Responses in MMR-proficient and MMR-deficient Early-Stage Colon Cancers

Chalabi et al.

  • Nature Medicine
  • April 2020

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

Phillips et al.

  • JAMA Oncology
  • March 2020

Prevalent and diverse intratumoral oncoprotein-specific CD8+ T cells within polyoma virus-driven Merkel cell carcinomas

Jing et al.

  • Cancer Immunology Research
  • March 2020

Peripheral T cell expansion predicts tumour infiltration and clinical response

Wu et al.

  • Nature
  • February 2020